All Updates

El Gobernador DeSantis promulgó la propuesta de ley HB885, la cual amplía el acceso de los pacientes a las pruebas de biomarcadores , una herramienta clave utilizada por médicos para identificar el tratamiento más eficaz contra el cáncer y otras enfermedades.

JUNEAU, Alaska -- The passage of two bills late in the 2024 legislative session marks a significant step forward in easing the cancer burden in Alaska. Senate Bill 91 expanded access to telehealth services for those dealing with life-threatening conditions and diseases, like cancer. Senate Bill 134, meanwhile, eliminated costs

Our 25 organizations, representing patients with serious health conditions and disabilities and their providers, applaud the Supreme Court’s unanimous ruling reversing the Fifth Circuit’s decision in Alliance for Hippocratic Medicine et al. v FDA et al, on the grounds that the plaintiffs don’t have standing in their challenge concerning the

Earlier today, the New Jersey State Assembly Financial Institutions & Insurance Committee voted to move the Louisa Carmen Medical Debt Relief Act forward. A3861, sponsored by Assemblywoman Verlina Reynolds-Jackson, Assemblyman Wayne DeAngelo, Assemblyman Anthony Verrelli and Assemblyman Herb Conaway, will now head to the Assembly floor for further consideration.

El Gobernador Ron DeSantis promulgó el presupuesto de Florida que incluye inversiones históricas en prioridades contra el cáncer para el Estado del Sol. ACS CAN aplaude el significativo aumento de los fondos para muchas iniciativas importantes.

Today, the House Insurance Committee passed legislation that would increase access to biomarker testing.

El Gobernador Ron DeSantis promulgó el presupuesto de Florida que incluye inversiones históricas en prioridades contra el cáncer para el Estado del Sol. ACS CAN aplaude el significativo aumento de los fondos para muchas iniciativas importantes.

Earlier this morning, House Bill 1754 was voted out of the Senate Banking & Insurance Committee. This legislation, which aims to ensure that biomarker testing is covered by Medicaid and all other state-regulated insurance plans when patients need it, now advances to the Senate floor for consideration.

The Consumer Financial Protection Bureau (CFPB) released a proposed rule today to lessen the impact of medical debt on an individual’s credit.